✦ LIBER ✦

805 HCV-RNA STATUS AT WEEK 12 OF TREATMENT WITH PEGINTERFERON ALFA-2A/RBV PREDICTS SVR IN PATIENTS WITH PRIOR NON-RESPONSE TO PEGYLATED INTERFERON ALFA-2B/RBV: RESULTS FROM REPEAT STUDY

✍ Scribed by P. Marcellin; B. Freilich; P. Andreone; A. DiBisceglie; C.E. Brandao; K.R. Reddy; A. Craxi; A. Olveira; G. Teuber; D. Messinger; G. Hooper; M. Popescu; A. Tietz; D. Jensen

Book ID: 117376731
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 56 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60807-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1938 HCV-RNA Status At Week 12 of Treat

S1938 HCV-RNA Status At Week 12 of Treatment with Peginterferon Alfa-2a/RBV Predicts SVR in Patients with Prior Non-Response to Pegylated Interferon Alfa-2b/RBV: Results from Repeat Study

✍ Marcellin, Patrick; Freilich, Bradley L.; Andreone, Pietro; Di Bisceglie, Adrian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

507 Early prediction of sustained virolo

507 Early prediction of sustained virological response (SVR) during treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (RBV) (COPEGUS®) in patients with HCV/HIV co-infection: Results from the aids pegasys ribavirin international co-infectio (abstract withdrawn)

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB